Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Fulgent Genetics Inc (FLGT)

Fulgent Genetics Inc (FLGT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 199,823
  • Shares Outstanding, K 18,710
  • Annual Sales, $ 21,350 K
  • Annual Income, $ -5,610 K
  • 60-Month Beta 0.93
  • Price/Sales 9.73
  • Price/Cash Flow N/A
  • Price/Book 3.77

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.03
  • Number of Estimates 1
  • High Estimate 0.03
  • Low Estimate 0.03
  • Prior Year -0.03
  • Growth Rate Est. (year over year) +200.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.96 +20.65%
on 11/04/19
16.50 -34.48%
on 11/11/19
-0.70 (-6.08%)
since 10/18/19
3-Month
8.96 +20.65%
on 11/04/19
16.50 -34.48%
on 11/11/19
+0.18 (+1.69%)
since 08/16/19
52-Week
3.05 +254.43%
on 11/20/18
16.50 -34.48%
on 11/11/19
+7.48 (+224.62%)
since 11/16/18

Most Recent Stories

More News
Buy These 5 Top-Ranked Stocks With Upgraded Broker Ratings

By following broker rating upgrades, an investor can easily find attractive stocks.

HPE : 17.28 (+0.29%)
SAH : 34.15 (-0.15%)
REGN : 340.19 (-1.36%)
EAT : 45.46 (+3.11%)
FLGT : 10.81 (+1.22%)
Fulgent Genetics Announces Pricing of Public Offering of Common Stock

Fulgent Genetics (NASDAQ: FLGT) ("Fulgent Genetics" or the "Company"), a provider of comprehensive genetic testing and Next Generation Sequencing (NGS) solutions, today announced the pricing of its previously...

FLGT : 10.81 (+1.22%)
Fulgent Genetics Announces Proposed Public Offering of Common Stock

Fulgent Genetics (NASDAQ: FLGT) ("Fulgent Genetics" or the "Company"), a provider of comprehensive genetic testing and Next Generation Sequencing (NGS) solutions, today announced that it has commenced...

FLGT : 10.81 (+1.22%)
Find Strong Buy Stocks with this Filtered Zacks Rank 5 Stock Screener

Find Strong Buy Stocks with this Filtered Zacks Rank 5 Stock Screener

ORN : 5.86 (+2.45%)
FLGT : 10.81 (+1.22%)
EURN : 10.82 (-1.64%)
FULGENT GENETIC (FLGT) Is Up 68.12% in One Week: What You Should Know

Does FULGENT GENETIC (FLGT) have what it takes to be a top stock pick for momentum investors? Let's find out.

FLGT : 10.81 (+1.22%)
Top Ranked Momentum Stocks to Buy for November 11th

Top Ranked Momentum Stocks to Buy for November 11th

LUNA : 6.48 (-0.15%)
ITCI : 8.65 (-4.10%)
FLGT : 10.81 (+1.22%)
Surging Earnings Estimates Signal Upside for FULGENT GENETIC (FLGT) Stock

FULGENT GENETIC (FLGT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

FLGT : 10.81 (+1.22%)
Fulgent Genetics Reports Third Quarter 2019 Financial Results

Third Quarter 2019 Results:

FLGT : 10.81 (+1.22%)
Fulgent Genetics to Announce Third Quarter 2019 Financial Results on Monday November 4, 2019

Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent Genetics" or the "company") today announced that it will release its third quarter 2019 financial results after the market closes on Monday November 4, 2019....

FLGT : 10.81 (+1.22%)
Fulgent Genetics Launches Picture Genetics, a Consumer-Initiated Genetic Testing Offering

Fulgent Genetics (NASDAQ: FLGT) ("Fulgent Genetics" or the "company"), a provider of comprehensive genetic testing and Next Generation Sequencing (NGS) solutions, today announced the launch of Picture...

FLGT : 10.81 (+1.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade FLGT with:

Business Summary

Fulgent Genetics, Inc. is a technology company. It provide genetic testing services to physicians with clinically actionable diagnostic information. The Company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools...

See More

Key Turning Points

2nd Resistance Point 11.64
1st Resistance Point 11.23
Last Price 10.81
1st Support Level 10.11
2nd Support Level 9.40

See More

52-Week High 16.50
Fibonacci 61.8% 11.36
Last Price 10.81
Fibonacci 50% 9.77
Fibonacci 38.2% 8.19
52-Week Low 3.05

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar